Blocking KCa3.1 channels increases tumor cell killing by a subpopulation of human natural killer lymphocytes.

Natural killer (NK) cells are large granular lymphocytes that participate in both innate and adaptive immune responses against tumors and pathogens. They are also involved in other conditions, including organ rejection, graft-versus-host disease, recurrent spontaneous abortions, and autoimmune disea...

Full description

Bibliographic Details
Main Authors: Shyny Koshy, Danli Wu, Xueyou Hu, Rajeev B Tajhya, Redwan Huq, Fatima S Khan, Michael W Pennington, Heike Wulff, Patricia Yotnda, Christine Beeton
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2013-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3795664?pdf=render
_version_ 1811225203505627136
author Shyny Koshy
Danli Wu
Xueyou Hu
Rajeev B Tajhya
Redwan Huq
Fatima S Khan
Michael W Pennington
Heike Wulff
Patricia Yotnda
Christine Beeton
author_facet Shyny Koshy
Danli Wu
Xueyou Hu
Rajeev B Tajhya
Redwan Huq
Fatima S Khan
Michael W Pennington
Heike Wulff
Patricia Yotnda
Christine Beeton
author_sort Shyny Koshy
collection DOAJ
description Natural killer (NK) cells are large granular lymphocytes that participate in both innate and adaptive immune responses against tumors and pathogens. They are also involved in other conditions, including organ rejection, graft-versus-host disease, recurrent spontaneous abortions, and autoimmune diseases such as multiple sclerosis. We demonstrate that human NK cells express the potassium channels Kv1.3 and KCa3.1. Expression of these channels does not vary with expression levels of maturation markers but varies between adherent and non-adherent NK cell subpopulations. Upon activation by mitogens or tumor cells, adherent NK (A-NK) cells preferentially up-regulate KCa3.1 and non-adherent (NA-NK) cells preferentially up-regulate Kv1.3. Consistent with this different phenotype, A-NK and NA-NK do not display the same sensitivity to the selective KCa3.1 blockers TRAM-34 and NS6180 and to the selective Kv1.3 blockers ShK-186 and PAP-1 in functional assays. Kv1.3 block inhibits the proliferation and degranulation of NA-NK cells with minimal effects on A-NK cells. In contrast, blocking KCa3.1 increases the degranulation and cytotoxicity of A-NK cells, but not of NA-NK cells. TRAM-34, however, does not affect their ability to form conjugates with target tumor cells, to migrate, or to express chemokine receptors. TRAM-34 and NS6180 also increase the proliferation of both A-NK and NA-NK cells. This results in a TRAM-34-induced increased ability of A-NK cells to reduce in vivo tumor growth. Taken together, our results suggest that targeting KCa3.1 on NK cells with selective blockers may be beneficial in cancer immunotherapy.
first_indexed 2024-04-12T09:02:49Z
format Article
id doaj.art-9d49b71d5a4e498ba0b089b1c075835f
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-04-12T09:02:49Z
publishDate 2013-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-9d49b71d5a4e498ba0b089b1c075835f2022-12-22T03:39:11ZengPublic Library of Science (PLoS)PLoS ONE1932-62032013-01-01810e7674010.1371/journal.pone.0076740Blocking KCa3.1 channels increases tumor cell killing by a subpopulation of human natural killer lymphocytes.Shyny KoshyDanli WuXueyou HuRajeev B TajhyaRedwan HuqFatima S KhanMichael W PenningtonHeike WulffPatricia YotndaChristine BeetonNatural killer (NK) cells are large granular lymphocytes that participate in both innate and adaptive immune responses against tumors and pathogens. They are also involved in other conditions, including organ rejection, graft-versus-host disease, recurrent spontaneous abortions, and autoimmune diseases such as multiple sclerosis. We demonstrate that human NK cells express the potassium channels Kv1.3 and KCa3.1. Expression of these channels does not vary with expression levels of maturation markers but varies between adherent and non-adherent NK cell subpopulations. Upon activation by mitogens or tumor cells, adherent NK (A-NK) cells preferentially up-regulate KCa3.1 and non-adherent (NA-NK) cells preferentially up-regulate Kv1.3. Consistent with this different phenotype, A-NK and NA-NK do not display the same sensitivity to the selective KCa3.1 blockers TRAM-34 and NS6180 and to the selective Kv1.3 blockers ShK-186 and PAP-1 in functional assays. Kv1.3 block inhibits the proliferation and degranulation of NA-NK cells with minimal effects on A-NK cells. In contrast, blocking KCa3.1 increases the degranulation and cytotoxicity of A-NK cells, but not of NA-NK cells. TRAM-34, however, does not affect their ability to form conjugates with target tumor cells, to migrate, or to express chemokine receptors. TRAM-34 and NS6180 also increase the proliferation of both A-NK and NA-NK cells. This results in a TRAM-34-induced increased ability of A-NK cells to reduce in vivo tumor growth. Taken together, our results suggest that targeting KCa3.1 on NK cells with selective blockers may be beneficial in cancer immunotherapy.http://europepmc.org/articles/PMC3795664?pdf=render
spellingShingle Shyny Koshy
Danli Wu
Xueyou Hu
Rajeev B Tajhya
Redwan Huq
Fatima S Khan
Michael W Pennington
Heike Wulff
Patricia Yotnda
Christine Beeton
Blocking KCa3.1 channels increases tumor cell killing by a subpopulation of human natural killer lymphocytes.
PLoS ONE
title Blocking KCa3.1 channels increases tumor cell killing by a subpopulation of human natural killer lymphocytes.
title_full Blocking KCa3.1 channels increases tumor cell killing by a subpopulation of human natural killer lymphocytes.
title_fullStr Blocking KCa3.1 channels increases tumor cell killing by a subpopulation of human natural killer lymphocytes.
title_full_unstemmed Blocking KCa3.1 channels increases tumor cell killing by a subpopulation of human natural killer lymphocytes.
title_short Blocking KCa3.1 channels increases tumor cell killing by a subpopulation of human natural killer lymphocytes.
title_sort blocking kca3 1 channels increases tumor cell killing by a subpopulation of human natural killer lymphocytes
url http://europepmc.org/articles/PMC3795664?pdf=render
work_keys_str_mv AT shynykoshy blockingkca31channelsincreasestumorcellkillingbyasubpopulationofhumannaturalkillerlymphocytes
AT danliwu blockingkca31channelsincreasestumorcellkillingbyasubpopulationofhumannaturalkillerlymphocytes
AT xueyouhu blockingkca31channelsincreasestumorcellkillingbyasubpopulationofhumannaturalkillerlymphocytes
AT rajeevbtajhya blockingkca31channelsincreasestumorcellkillingbyasubpopulationofhumannaturalkillerlymphocytes
AT redwanhuq blockingkca31channelsincreasestumorcellkillingbyasubpopulationofhumannaturalkillerlymphocytes
AT fatimaskhan blockingkca31channelsincreasestumorcellkillingbyasubpopulationofhumannaturalkillerlymphocytes
AT michaelwpennington blockingkca31channelsincreasestumorcellkillingbyasubpopulationofhumannaturalkillerlymphocytes
AT heikewulff blockingkca31channelsincreasestumorcellkillingbyasubpopulationofhumannaturalkillerlymphocytes
AT patriciayotnda blockingkca31channelsincreasestumorcellkillingbyasubpopulationofhumannaturalkillerlymphocytes
AT christinebeeton blockingkca31channelsincreasestumorcellkillingbyasubpopulationofhumannaturalkillerlymphocytes